| Literature DB >> 35399436 |
Ahmed Alasker1,2,3, Saeed Bin Hamri1,2,3, Yasser A Noureldin1,2,3,4, Abdullah A Alsaghyir2,3, Ghassan I Alhajress2,3.
Abstract
Introduction Urolithiasis is one of the most common conditions encountered in clinical practice with the prevalence increasing globally in the last few decades. Urolithiasis has been found to be more common in areas with a hot climate, such as Saudi Arabia. The aim of this study was to determine the characteristics and the types of urolithiasis most frequently found in the Eastern Region of Saudi Arabia. Methods This was a single-center retrospective cohort study based on data extracted from an electronic hospital information system (BESTCare) of all patients diagnosed with urolithiasis at King Abdulaziz Hospital, a tertiary care center in Saudi Arabia's Eastern Region. From January 2013 to December 2016, all adult patients aged 18 and up who presented with urinary calculi (renal and ureter) were included in the study. Results A total of 235 patients were reviewed, with a mean age of 48.52 years. Renal calculi were more prevalent in males (74.5%). Calcium oxalate was the predominant type (76%), followed by uric acid calculi (18%) and cystine calculi (4.8%). A small proportion (1.2%) was calcium phosphate calculi. The most frequently associated comorbidity was hypertension (17.9%). The majority (78.5%) had a stone removal through a ureteroscopy and 8.2% by percutaneous nephrolithotomy (PCNL). The mean stone size was 12.2 ± 9.91 mm, with a mean stone Hounsfield unit (HU) of 789.9. The mean urinary PH at stone incident was 6.77, and the mean creatinine level was 92.4mmol. Conclusion This study showed that males were more affected by urolithiasis, compared to females in the Eastern Region. Furthermore, calcium oxalate was the predominant type. These findings are consistent with the literature and they highlighted the necessity for further studies in this area, to provide insight into the pathophysiology and incidence of renal calculi for improving patient care.Entities:
Keywords: kidney calculi; nephrolithiasis; renal calculi; renal stone disease; stone analysis; urolithiasis
Year: 2022 PMID: 35399436 PMCID: PMC8985478 DOI: 10.7759/cureus.22913
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Incidence of renal stone according to age, gender, BMI, and comorbidities
*BMI (body mass index), HTN (hypertension), NIDDM (non-insulin-dependent diabetes mellitus), IDDM (insulin-dependent diabetes mellitus), DLP (dyslipidemia).
| Study variables | N (%) |
| Age in years (mean ± SD) | 45.9 ± 14.0 |
| Gender: | |
| Male | 175 (74.5%) |
| Female | 60 (25.5%) |
| BMI in kg/m2 (mean ± SD) | 29.8 ± 6.56 |
| Comorbidities: | |
| HTN | 42 (17.9%) |
| NIDDM | 37 (15.7%) |
| IDDM | 09 (03.8%) |
| DLP | 06 (02.6%) |
Figure 1Distribution of the type of renal stone
Prevalence of renal stone by location
*UC (upper calyx), MC (middle calyx), LC (lower calyx).
| Variables | N (%) |
| UC | 63 (26.8%) |
| MC | 76 (32.3%) |
| LC | 115 (48.9%) |
| Renal pelvis | 51 (21.7%) |
| Upper ureter | 30 (12.8%) |
| Mid ureter | 06 (02.6%) |
| Lower ureter | 09 (03.8%) |
| PH (mean ± SD) | 6.77 ± 6.34 |
| Stone burden in mm (mean ± SD) | 12.2 ± 9.91 |
Association between the type of renal stone among the baseline and clinical characteristics of the patients
* IDDM (insulin-dependent diabetes mellitus), NIDDM (non-insulin-dependent diabetes mellitus), HTN (hypertension), DLP (dyslipidemia). BMI (body mass index), Hb (hemoglobin§ P-value has been calculated using Fischer exact test.
‡ P-value has been calculated using the one-way ANOVA test.
** Significant at p<0.05 level.
| Factor | Ca oxalate N (%) | Uric Acid N (%) | Cystine N (%) | Ca Phosphate N (%) | P-value § |
| Total No | 127 | 30 | 8 | 2 | |
| Percentage (%) | 76% | 18% | 4.8% | 1.2% | |
| Gender | |||||
| Male | 102 (80.3%) | 27 (90.0%) | 0 | 02 (100%) | <0.001 ** |
| Female | 25 (19.7%) | 03 (10.0%) | 08 (100%) | 0 | |
| Comorbidities | |||||
| IDDM | 05 (03.9%) | 03 (10.0%) | 0 | 0 | 0.407 |
| NIDDM | 19 (15.0%) | 07 (23.3%) | 0 | 0 | 0.446 |
| HTN | 17 (13.4%) | 09 (30.0%) | 0 | 0 | 0.090 |
| DLP | 03 (02.4%) | 02 (06.7%) | 0 | 0 | 0.446 |
| Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | P-value ‡ | |
| Age in years | 48.2 ± 13.3 | 44.9 ± 11.9 | 31.9 ± 3.04 | 55.0 ± 19.8 | 0.004 ** |
| BMI in kg/m2 | 29.8 ± 6.06 | 31.7 ± 4.48 | 31.7 ± 5.70 | 30.3 ± 0 | 0.386 |
| PH | 6.23 ± 0.76 | 5.57 ± 0.58 | 7.50 ± 0.89 | 7.00 ± 1.41 | <0.001 ** |
| Stone size in mm | 10.5 ± 7.55 | 17.4 ± 11.5 | 10.2 ± 8.15 | 9.00 ± 0 | 0.002 ** |
| Creatinine clearance | 91.3 ± 26.2 | 87.4 ± 14.5 | 85.5 ± 14.8 | -- | 0.778 |
| Hb (%) | 13.4 ± 1.94 | 13.7 ± 2.05 | 12.0 ± 0.00 | -- | 0.496 |